Covidien, a leading global provider of healthcare products, has increased manufacturing of its made in the United States cotton-based wound care products to ensure there are no disruptions in the supply of these materials.
The Food and Drug Administration (FDA) recently announced an import alert on certain steam-sterilized plastic bandages and cotton pads that are imported from China. These products have been detained without physical examination due to microbiological contamination. Covidien does not import or distribute any of the steam-sterilized products that are impacted by the FDAs decision.Â
Microbiological analysis by the FDA's Winchester Engineering and Analytical Center using the U.S.P. Sterility Test Method revealed that the detained plastic bandages and cotton pads were contaminated with various viable microorganisms. The FDA has indicated that the action to restrict importation of these products is due to the seriousness of the hazard posed by microbial contamination of sterile products.
The full import alert can be accessed HERE.
Covidien manufactures a full line of cotton-based wound care products in Augusta, Ga., where all products go through a stringent quality control process with continued monitoring to ensure quality and safety.
Product safety is, and always will be, a priority at Covidien, says Kristin Dietzler, vice president and general manager of nursing care at Covidien. We continue to be a reliable partner, consistently delivering quality wound care products that meet the high standards of patients and caregivers alike. Covidien is proud to maintain manufacturing and sterilization for the vast majority of our wound care products the United States.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.